Skip to main content
Equibles
ENSG logo

ENSG · Ensign Group, Inc

Track ENSG — free

Use ENSG with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about ENSG

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$182.49 +0.00 (+0.00%) At close · Aug 19
Market Cap
$10.68B
Shares
58.28M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$182.49 Open$183.17 Day$181.91–184.92 52W close$147.13–215.83 Avg vol 30d403K Short int1.7M · 2.9% float · 3.2d Short vol54% Last earningsJul 29, 2026 DataJan 2020–Aug 2026 Filing10-Q · Jul 27

Up next

Next earnings call
Oct 28, 2026 Est · unconfirmed · in 10 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Jul 27, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Neutral
      SellHoldBuy
      Technical Neutral Momentum Neutral Sentiment Neutral Fundamentals Excellent Quant / Vol Moderate
      Market backdrop VIX 14.9 · calm Equity put/call 0.52
      Technical
      price trend
      Neutral
      50 / 200-day cross No cross
      Price vs 200-day avg −0%
      below
      Price vs 50-day avg +8%
      above
      RSI (14) 61
      neutral
      MACD trend Negative
      52-week position 51%
      mid-range
      Momentum
      relative strength
      Neutral
      1-month return +8%
      trailing
      6-month return −14%
      trailing
      YTD return +5%
      this year
      Relative strength −26%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50d $170 › 200d $183 — 200d above 50d
      Institutional flow Distributing
      -5% holders QoQ · +83 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Falling
      2.89% of float · ▼ -22.3% MoM · 3.2 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      544 holders — mid 3-yr range
      Squeeze score 54
      elevated · 0–100
      Fundamentals
      Excellent
      Revenue growth +19%
      Y/Y
      EPS growth +14%
      Y/Y
      Free cash flow $492.7M
      Valuation P/E 28.7
      rich
      Buyback $60.0M
      remaining
      Balance sheet $362.1M
      net cash
      Quant / Vol
      risk profile
      Moderate
      Volatility 28%
      annualized · 1-yr
      Max drawdown −32%
      past year
      ATR 2.3%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Beat or met 3 of last 6
      Latest guidance · from the 8-K filed Jul 27, 2026
      Earnings per diluted share · annual 2026 $7.75 – $7.85
      Revenue · annual 2026 $5.87B – $5.92B
      Prior guidance period ended · from the 8-K filed Nov 3, 2025
      Earnings guidance · annual 2025 $6.48 – $6.54
      Revenue guidance · annual 2025 $5.05B – $5.07B
      Guided vs delivered · last 6 settled
      Earnings guidance annual 2025
      guided $6.48 – $6.54
      $5.84 Miss −10.3%
      Revenue guidance annual 2025
      guided $5.05B – $5.07B
      $5.06B In line
      Annual 2024 earnings guidance annual 2024
      guided $5.29 – $5.47
      $5.12 Miss −4.8%
      Annual revenue guidance annual 2024
      guided $4.13B – $4.17B
      $4.26B Beat +2.7%

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Neutral
      1 · 4 · 1
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      −0% Neutral
      Price vs 50-day avg
      +8% Bullish
      RSI (14)
      61 Neutral
      MACD trend
      Negative Bearish
      52-week position
      51% Neutral
      Market signals — smart money & positioning
      Mixed
      Trend (MA cross) No cross
      50d $170 › 200d $183 — 200d above 50d
      Institutional flow Distributing
      -5% holders QoQ · +83 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Falling
      2.89% of float · ▼ -22.3% MoM · 3.2 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      544 holders — mid 3-yr range
      Price context
      position in its 52-week range
      Range low $147 Now $182 · 51% Range high $216
      vs 200-day avg 0% vs 50-day avg +8%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      Actual patient days 5,913,675 Six Months Ended June 30, 2026 —
      Adjusted Earnings Per Share non-GAAP $3.77 Six Months Ended June 30, 2026 —
      Adjusted EBITDA non-GAAP 352.31M Six Months Ended June 30, 2026 —
      Adjusted EBITDAR non-GAAP 484.23M Six Months Ended June 30, 2026 —
      Adjusted EBT non-GAAP 299.59M Six Months Ended June 30, 2026 —
      affiliated facilities 398 second quarter ended June 30, 2026 —
      GAAP → non-GAAP reconciliation
      GAAP Segment income $12.07M
      +$12.68M Depreciation and amortization
      = FFO $24.75M
      Number of campuses at period end 32 Three Months Ended June 30, 2026 —
      Number of facilities at period end 348 Six Months Ended June 30, 2026 —
      Number of healthcare operations 398 as of June 30, 2026 —
      Number of healthcare operations with senior living 32 as of June 30, 2026 —
      Number of real estate assets operated by an Ensign affiliate 144 as of June 30, 2026 —
      Number of real estate assets owned 183 as of June 30, 2026 —
      Number of Standard Bearer owned properties 177 as of June 30, 2026 —
      Occupancy percentage — Operational beds 83.4% Six Months Ended June 30, 2026 —
      owned real estate assets 183 second quarter ended June 30, 2026 —
      Same Facility occupancy 84.1% second quarter ended June 30, 2026 —
      Skilled mix by nursing days 31% Three Months Ended June 30, 2026 —
      Skilled mix by nursing revenue 50% Three Months Ended June 30, 2026 —
      Standard Bearer owned properties leased to an Ensign-affiliated operator 140 as of June 30, 2026 —
      Standard Bearer owned properties leased to third-party operators 38 as of June 30, 2026 —
      Standard Bearer rental revenue $44.1M the quarter —
      Standard Bearer rental revenue from Ensign affiliated operations $37.8M the quarter —
      Transitioning Facility occupancy 84.7% second quarter ended June 30, 2026 —
      Same Facilities skilled days 4.4% first quarter of 2026 —
      Transitioning Facilities skilled days 9.3% first quarter of 2026 —
      Transitioning Facility number of facilities at period end 48 quarter ended December 31, 2025 —

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Medical Care Facilities — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      ENSG
      Ensign Group, Inc
      this stock
      		$10.68B +4.8% +18.7% 28.7 2.9%
      HCA
      HCA Healthcare, Inc.
      		 $90.30B -12.8% +7.1% 14.0 2.7%
      FSNUY
      Fresenius SE & Co. KGaA
      		 $30.84B -4.5% — — 0.0%
      THC
      Tenet Healthcare Corp
      		 $21.76B +35.1% +0.9% 10.4 4.0%
      FMS
      Fresenius Medical Care AG
      		 $12.69B +0.1% +5.9% — 0.5%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Reducing
      Holders
      544
      % held
      90.9%
      Net QoQ
      -621.8K sh
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      523
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      1.7M
      Days to cover
      3.2d
      Change
      -483.3K sh
      View
      Short Volume
      Short vol %
      54%
      As of
      Aug 19, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      374
      Value
      $68.0K
      As of
      Jul 30, 2026
      View
      Off-Exchange
      Off-exchange %
      39.6%
      Week of
      Jul 13, 2026
      Off-exch Lit
      View
      Financials
      Financials
      Revenue (FY)
      $5.1B
      Net income (FY)
      $344.0M
      EPS diluted
      $5.84
      View
      Buybacks
      Authorized
      $100.0M
      Remaining
      $60.0M
      Spent Remaining
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Jul 27, 2026
      This year
      10
      View
      Proposed Sales
      Value
      $68.8K
      Shares
      375
      Filed
      Jul 27, 2026
      View
      Earnings & Events
      Earnings Calls
      Last call
      Jul 29, 2026
      View
      Investor Relations
      Latest news
      The Ensign Group Reports Second Q…
      Published
      Jul 27, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      ENSG +0.5% +7.9% -14.2% +2.4% +4.8%
      SPY -0.4% +2.9% +11.6% +3.0% +12.8%
      vs SPY +0.9% +5.0% -25.8% -0.5% -8.0%

      Capital returns

      Latest dividend
      $0.065 / share · ex Jun 30, 2026
      Raised 3.2%
      Paid (TTM)
      $0.258 / share · 4 payouts
      Dividend yield (TTM, derived)
      0.14%
      Buyback program · as of Jun 30, 2026
      Authorized
      $100.00M
      Spent (derived)
      $40.00M
      Remaining
      $60.00M
      Spent Remaining

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 1125376 CUSIP 29358P101 13F (30d) 484 filings 477 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)